 | • レポートコード：QAF27562 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗体市場について種類別（IgM、IgG、IgA、その他）、用途別（治療、研究、診断）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗体市場の概要 ・世界の主要地域別抗体市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗体市場規模2016-2021：種類別（IgM、IgG、IgA、その他） ・世界の抗体市場予測2012-2027：種類別（IgM、IgG、IgA、その他） ・世界の抗体市場規模2016-2021：用途別（治療、研究、診断） ・世界の抗体市場予測2012-2027：用途別（治療、研究、診断） ・抗体のアメリカ市場規模と予測2016-2021 ・抗体のヨーロッパ市場規模と予測2016-2021 ・抗体の中国市場規模と予測2016-2021 ・抗体の日本市場規模と予測2016-2021 ・抗体の東南アジア市場規模と予測2016-2021 ・抗体のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Johnson & Johnson、Merck、Novartis、AbbVie、Amgen、Pfizer、Bayer、Lilly、Bristol-Myers Squibb、GlaxoSmithKline、Biogen、AstraZeneca、Sanofi、Alexion Pharmaceuticals、Seattle Genetics） ・抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗体の市場動向・機会・課題 ・調査の結論 |
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.
In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%
In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.
The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.
Market Analysis and Insights: Global Antibody Market
The global Antibody market was valued at US$ 9091.5 in 2020 and will reach US$ 12390 million by the end of 2027, growing at a CAGR of 5.3% during 2022-2027.
Global Antibody Scope and Market Size
The global Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
The Antibody market is analysed and market size information is provided by regions (countries). Segment by Application, the Antibody market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
1 Antibody Market Overview
1.1 Antibody Product Scope
1.2 Antibody Segment by Type
1.2.1 Global Antibody Sales by Type (2016 & 2021 & 2027)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Segment by Application
1.3.1 Global Antibody Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Antibody Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antibody Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antibody Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antibody Price Trends (2016-2027)
2 Antibody Estimates and Forecasts by Region
2.1 Global Antibody Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antibody Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antibody Sales Market Share by Region (2016-2021)
2.2.2 Global Antibody Revenue Market Share by Region (2016-2021)
2.3 Global Antibody Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antibody Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antibody Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antibody Estimates and Projections (2016-2027)
2.4.2 Europe Antibody Estimates and Projections (2016-2027)
2.4.3 China Antibody Estimates and Projections (2016-2027)
2.4.4 Japan Antibody Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antibody Estimates and Projections (2016-2027)
2.4.6 India Antibody Estimates and Projections (2016-2027)
3 Global Antibody Competition Landscape by Players
3.1 Global Top Antibody Players by Sales (2016-2021)
3.2 Global Top Antibody Players by Revenue (2016-2021)
3.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody as of 2020)
3.4 Global Antibody Average Price by Company (2016-2021)
3.5 Manufacturers Antibody Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antibody Market Size by Type
4.1 Global Antibody Historic Market Review by Type (2016-2021)
4.1.1 Global Antibody Sales Market Share by Type (2016-2021)
4.1.2 Global Antibody Revenue Market Share by Type (2016-2021)
4.1.3 Global Antibody Price by Type (2016-2021)
4.2 Global Antibody Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antibody Sales Forecast by Type (2022-2027)
4.2.2 Global Antibody Revenue Forecast by Type (2022-2027)
4.2.3 Global Antibody Price Forecast by Type (2022-2027)
5 Global Antibody Market Size by Application
5.1 Global Antibody Historic Market Review by Application (2016-2021)
5.1.1 Global Antibody Sales Market Share by Application (2016-2021)
5.1.2 Global Antibody Revenue Market Share by Application (2016-2021)
5.1.3 Global Antibody Price by Application (2016-2021)
5.2 Global Antibody Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antibody Sales Forecast by Application (2022-2027)
5.2.2 Global Antibody Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibody Price Forecast by Application (2022-2027)
6 North America Antibody Market Facts & Figures
6.1 North America Antibody Sales by Company
6.1.1 North America Antibody Sales by Company (2016-2021)
6.1.2 North America Antibody Revenue by Company (2016-2021)
6.2 North America Antibody Sales Breakdown by Type
6.2.1 North America Antibody Sales Breakdown by Type (2016-2021)
6.2.2 North America Antibody Sales Breakdown by Type (2022-2027)
6.3 North America Antibody Sales Breakdown by Application
6.3.1 North America Antibody Sales Breakdown by Application (2016-2021)
6.3.2 North America Antibody Sales Breakdown by Application (2022-2027)
7 Europe Antibody Market Facts & Figures
7.1 Europe Antibody Sales by Company
7.1.1 Europe Antibody Sales by Company (2016-2021)
7.1.2 Europe Antibody Revenue by Company (2016-2021)
7.2 Europe Antibody Sales Breakdown by Type
7.2.1 Europe Antibody Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antibody Sales Breakdown by Type (2022-2027)
7.3 Europe Antibody Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Antibody Market Facts & Figures
8.1 China Antibody Sales by Company
8.1.1 China Antibody Sales by Company (2016-2021)
8.1.2 China Antibody Revenue by Company (2016-2021)
8.2 China Antibody Sales Breakdown by Type
8.2.1 China Antibody Sales Breakdown by Type (2016-2021)
8.2.2 China Antibody Sales Breakdown by Type (2022-2027)
8.3 China Antibody Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Antibody Market Facts & Figures
9.1 Japan Antibody Sales by Company
9.1.1 Japan Antibody Sales by Company (2016-2021)
9.1.2 Japan Antibody Revenue by Company (2016-2021)
9.2 Japan Antibody Sales Breakdown by Type
9.2.1 Japan Antibody Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antibody Sales Breakdown by Type (2022-2027)
9.3 Japan Antibody Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antibody Market Facts & Figures
10.1 Southeast Asia Antibody Sales by Company
10.1.1 Southeast Asia Antibody Sales by Company (2016-2021)
10.1.2 Southeast Asia Antibody Revenue by Company (2016-2021)
10.2 Southeast Asia Antibody Sales Breakdown by Type
10.2.1 Southeast Asia Antibody Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antibody Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antibody Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Antibody Market Facts & Figures
11.1 India Antibody Sales by Company
11.1.1 India Antibody Sales by Company (2016-2021)
11.1.2 India Antibody Revenue by Company (2016-2021)
11.2 India Antibody Sales Breakdown by Type
11.2.1 India Antibody Sales Breakdown by Type (2016-2021)
11.2.2 India Antibody Sales Breakdown by Type (2022-2027)
11.3 India Antibody Sales Breakdown by Application
11.3.1 India Antibody Sales Breakdown by Application (2016-2021)
11.3.2 India Antibody Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antibody Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Antibody Products Offered
12.1.5 Roche Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Antibody Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Antibody Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Antibody Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Antibody Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Antibody Products Offered
12.4.5 Novartis Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Business Overview
12.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Antibody Products Offered
12.5.5 AbbVie Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Business Overview
12.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amgen Antibody Products Offered
12.6.5 Amgen Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Antibody Products Offered
12.7.5 Pfizer Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Business Overview
12.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer Antibody Products Offered
12.8.5 Bayer Recent Development
12.9 Lilly
12.9.1 Lilly Corporation Information
12.9.2 Lilly Business Overview
12.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lilly Antibody Products Offered
12.9.5 Lilly Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Corporation Information
12.10.2 Bristol-Myers Squibb Business Overview
12.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bristol-Myers Squibb Antibody Products Offered
12.10.5 Bristol-Myers Squibb Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Business Overview
12.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Antibody Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Biogen
12.12.1 Biogen Corporation Information
12.12.2 Biogen Business Overview
12.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biogen Antibody Products Offered
12.12.5 Biogen Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Corporation Information
12.13.2 AstraZeneca Business Overview
12.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2016-2021)
12.13.4 AstraZeneca Antibody Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Sanofi
12.14.1 Sanofi Corporation Information
12.14.2 Sanofi Business Overview
12.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sanofi Antibody Products Offered
12.14.5 Sanofi Recent Development
12.15 Alexion Pharmaceuticals
12.15.1 Alexion Pharmaceuticals Corporation Information
12.15.2 Alexion Pharmaceuticals Business Overview
12.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Alexion Pharmaceuticals Antibody Products Offered
12.15.5 Alexion Pharmaceuticals Recent Development
12.16 Seattle Genetics
12.16.1 Seattle Genetics Corporation Information
12.16.2 Seattle Genetics Business Overview
12.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Seattle Genetics Antibody Products Offered
12.16.5 Seattle Genetics Recent Development
13 Antibody Manufacturing Cost Analysis
13.1 Antibody Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody
13.4 Antibody Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody Distributors List
14.3 Antibody Customers
15 Market Dynamics
15.1 Antibody Market Trends
15.2 Antibody Drivers
15.3 Antibody Market Challenges
15.4 Antibody Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antibody Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antibody Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antibody Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antibody Sales (MT) by Region (2016-2021)
Table 5. Global Antibody Sales Market Share by Region (2016-2021)
Table 6. Global Antibody Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antibody Revenue Share by Region (2016-2021)
Table 8. Global Antibody Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Antibody Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antibody Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antibody Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antibody Sales (MT) of Key Companies (2016-2021)
Table 13. Global Antibody Sales Share by Company (2016-2021)
Table 14. Global Antibody Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antibody Revenue Share by Company (2016-2021)
Table 16. Global Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody as of 2020)
Table 17. Global Antibody Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Antibody Manufacturing Sites and Area Served
Table 19. Manufacturers Antibody Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antibody Sales (MT) by Type (2016-2021)
Table 22. Global Antibody Sales Share by Type (2016-2021)
Table 23. Global Antibody Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antibody Price (USD/MT) by Type (2016-2021)
Table 25. Global Antibody Sales Share by Type (2022-2027)
Table 26. Global Antibody Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antibody Revenue Share by Type (2022-2027)
Table 28. Global Antibody Price (USD/MT) by Type (2022-2027)
Table 29. Global Antibody Sales (MT) by Application (2016-2021)
Table 30. Global Antibody Sales Share by Application (2016-2021)
Table 31. Global Antibody Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antibody Price (USD/MT) by Application (2016-2021)
Table 33. Global Antibody Sales (MT) by Application (2022-2027)
Table 34. Global Antibody Sales Share by Application (2022-2027)
Table 35. Global Antibody Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antibody Revenue Share by Application (2022-2027)
Table 37. Global Antibody Price (USD/MT) by Application (2022-2027)
Table 38. North America Antibody Sales (MT) by Company (2016-2021)
Table 39. North America Antibody Sales Market Share by Company (2016-2021)
Table 40. North America Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antibody Revenue Market Share by Company (2016-2021)
Table 42. North America Antibody Sales by Type (2016-2021) & (MT)
Table 43. North America Antibody Sales Market Share by Type (2016-2021)
Table 44. North America Antibody Sales by Type (2022-2027) & (MT)
Table 45. North America Antibody Sales Market Share by Type (2022-2027)
Table 46. North America Antibody Sales by Application (2016-2021) & (MT)
Table 47. North America Antibody Sales Market Share by Application (2016-2021)
Table 48. North America Antibody Sales by Application (2022-2027) & (MT)
Table 49. North America Antibody Sales Market Share by Application (2022-2027)
Table 50. Europe Antibody Sales (MT) by Company (2016-2021)
Table 51. Europe Antibody Sales Market Share by Company (2016-2021)
Table 52. Europe Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antibody Revenue Market Share by Company (2016-2021)
Table 54. Europe Antibody Sales by Type (2016-2021) & (MT)
Table 55. Europe Antibody Sales Market Share by Type (2016-2021)
Table 56. Europe Antibody Sales by Type (2022-2027) & (MT)
Table 57. Europe Antibody Sales Market Share by Type (2022-2027)
Table 58. Europe Antibody Sales by Application (2016-2021) & (MT)
Table 59. Europe Antibody Sales Market Share by Application (2016-2021)
Table 60. Europe Antibody Sales by Application (2022-2027) & (MT)
Table 61. Europe Antibody Sales Market Share by Application (2022-2027)
Table 62. China Antibody Sales (MT) by Company (2016-2021)
Table 63. China Antibody Sales Market Share by Company (2016-2021)
Table 64. China Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antibody Revenue Market Share by Company (2016-2021)
Table 66. China Antibody Sales by Type (2016-2021) & (MT)
Table 67. China Antibody Sales Market Share by Type (2016-2021)
Table 68. China Antibody Sales by Type (2022-2027) & (MT)
Table 69. China Antibody Sales Market Share by Type (2022-2027)
Table 70. China Antibody Sales by Application (2016-2021) & (MT)
Table 71. China Antibody Sales Market Share by Application (2016-2021)
Table 72. China Antibody Sales by Application (2022-2027) & (MT)
Table 73. China Antibody Sales Market Share by Application (2022-2027)
Table 74. Japan Antibody Sales (MT) by Company (2016-2021)
Table 75. Japan Antibody Sales Market Share by Company (2016-2021)
Table 76. Japan Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antibody Revenue Market Share by Company (2016-2021)
Table 78. Japan Antibody Sales by Type (2016-2021) & (MT)
Table 79. Japan Antibody Sales Market Share by Type (2016-2021)
Table 80. Japan Antibody Sales by Type (2022-2027) & (MT)
Table 81. Japan Antibody Sales Market Share by Type (2022-2027)
Table 82. Japan Antibody Sales by Application (2016-2021) & (MT)
Table 83. Japan Antibody Sales Market Share by Application (2016-2021)
Table 84. Japan Antibody Sales by Application (2022-2027) & (MT)
Table 85. Japan Antibody Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antibody Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Antibody Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antibody Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antibody Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Antibody Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antibody Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Antibody Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antibody Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Antibody Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antibody Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Antibody Sales Market Share by Application (2022-2027)
Table 98. India Antibody Sales (MT) by Company (2016-2021)
Table 99. India Antibody Sales Market Share by Company (2016-2021)
Table 100. India Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antibody Revenue Market Share by Company (2016-2021)
Table 102. India Antibody Sales by Type (2016-2021) & (MT)
Table 103. India Antibody Sales Market Share by Type (2016-2021)
Table 104. India Antibody Sales by Type (2022-2027) & (MT)
Table 105. India Antibody Sales Market Share by Type (2022-2027)
Table 106. India Antibody Sales by Application (2016-2021) & (MT)
Table 107. India Antibody Sales Market Share by Application (2016-2021)
Table 108. India Antibody Sales by Application (2022-2027) & (MT)
Table 109. India Antibody Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Roche Antibody Product
Table 114. Roche Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Antibody Product
Table 119. Johnson & Johnson Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Merck Antibody Product
Table 124. Merck Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Novartis Antibody Product
Table 129. Novartis Recent Development
Table 130. AbbVie Corporation Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. AbbVie Antibody Product
Table 134. AbbVie Recent Development
Table 135. Amgen Corporation Information
Table 136. Amgen Description and Business Overview
Table 137. Amgen Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Amgen Antibody Product
Table 139. Amgen Recent Development
Table 140. Pfizer Corporation Information
Table 141. Pfizer Description and Business Overview
Table 142. Pfizer Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Pfizer Antibody Product
Table 144. Pfizer Recent Development
Table 145. Bayer Corporation Information
Table 146. Bayer Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Bayer Description and Business Overview
Table 148. Bayer Antibody Product
Table 149. Bayer Recent Development
Table 150. Lilly Corporation Information
Table 151. Lilly Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Lilly Description and Business Overview
Table 153. Lilly Antibody Product
Table 154. Lilly Recent Development
Table 155. Bristol-Myers Squibb Corporation Information
Table 156. Bristol-Myers Squibb Description and Business Overview
Table 157. Bristol-Myers Squibb Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Bristol-Myers Squibb Antibody Product
Table 159. Bristol-Myers Squibb Recent Development
Table 160. GlaxoSmithKline Corporation Information
Table 161. GlaxoSmithKline Description and Business Overview
Table 162. GlaxoSmithKline Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. GlaxoSmithKline Antibody Product
Table 164. GlaxoSmithKline Recent Development
Table 165. Biogen Corporation Information
Table 166. Biogen Description and Business Overview
Table 167. Biogen Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Biogen Antibody Product
Table 169. Biogen Recent Development
Table 170. AstraZeneca Corporation Information
Table 171. AstraZeneca Description and Business Overview
Table 172. AstraZeneca Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. AstraZeneca Antibody Product
Table 174. AstraZeneca Recent Development
Table 175. Sanofi Corporation Information
Table 176. Sanofi Description and Business Overview
Table 177. Sanofi Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Sanofi Antibody Product
Table 179. Sanofi Recent Development
Table 180. Alexion Pharmaceuticals Corporation Information
Table 181. Alexion Pharmaceuticals Description and Business Overview
Table 182. Alexion Pharmaceuticals Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Alexion Pharmaceuticals Antibody Product
Table 184. Alexion Pharmaceuticals Recent Development
Table 185. Seattle Genetics Corporation Information
Table 186. Seattle Genetics Description and Business Overview
Table 187. Seattle Genetics Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Seattle Genetics Antibody Product
Table 189. Seattle Genetics Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Antibody Distributors List
Table 193. Antibody Customers List
Table 194. Antibody Market Trends
Table 195. Antibody Market Drivers
Table 196. Antibody Market Challenges
Table 197. Antibody Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Product Picture
Figure 2. Global Antibody Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibody Sales Market Share by Application in 2021 & 2027
Figure 6. Therapeutic Examples
Figure 7. Research Examples
Figure 8. Diagnostic Examples
Figure 9. Global Antibody Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Antibody Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Antibody Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Antibody Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Antibody Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Antibody Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Antibody Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Antibody Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Antibody Players Market Share by Revenue in Antibody: 2016 & 2020
Figure 28. Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Antibody Revenue Share by Type (2016-2021)
Figure 30. Global Antibody Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Antibody Revenue Share by Application (2016-2021)
Figure 32. Global Antibody Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Antibody Sales Market Share by Type in 2020
Figure 34. North America Antibody Sales Market Share by Application in 2020
Figure 35. Europe Antibody Sales Market Share by Type in 2020
Figure 36. Europe Antibody Sales Market Share by Application in 2020
Figure 37. China Antibody Sales Market Share by Type in 2020
Figure 38. China Antibody Sales Market Share by Application in 2020
Figure 39. Japan Antibody Sales Market Share by Type in 2020
Figure 40. Japan Antibody Sales Market Share by Application in 2020
Figure 41. Southeast Asia Antibody Sales Market Share by Type in 2020
Figure 42. Southeast Asia Antibody Sales Market Share by Application in 2020
Figure 43. India Antibody Sales Market Share by Type in 2020
Figure 44. India Antibody Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Antibody
Figure 47. Manufacturing Process Analysis of Antibody
Figure 48. Antibody Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
モノクローナル抗体診断試薬のグローバル市場2021 Monoclonal Antibody Diagnostic Reagents are reagents whose active ingredients are monoclonal antibodies to identify infectious agents, abnormal cells or elements of the body's response to disease. At present, in the foreign industrial developed countries the Monoclonal Antibody Diagnostic Reagents i…- 抗体薬物複合体（ADC）のグローバル市場2021 Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…
- 世界の抗ニューロフィラメントL抗体市場規模・現状・予測（2021年-2027年） Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon. Market Analysis and Insights: Global Anti Neurofilament L Antibody Market The …
- 世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-DPH5 Antibody Produced In Rabbit Market The global Anti-DPH5 Antibody Produced In Rabbit market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界のPD-1＆PD-L1抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global PD-1 and PD-L1 Antibody Market The global PD-1 and PD-L1 Antibody market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…